1 2480 105 EPIGENETIC UPREGULATION OF LARGE-CONDUCTANCE CA2+-ACTIVATED K+ CHANNEL EXPRESSION IN UTERINE VASCULAR ADAPTATION TO PREGNANCY. OUR PREVIOUS STUDY DEMONSTRATED THAT PREGNANCY INCREASED LARGE-CONDUCTANCE CA(2+)-ACTIVATED POTASSIUM CHANNEL BETA1 SUBUNIT (BKBETA1) EXPRESSION AND LARGE-CONDUCTANCE CA(2+)-ACTIVATED POTASSIUM CHANNEL ACTIVITY IN UTERINE ARTERIES, WHICH WERE ABROGATED BY CHRONIC HYPOXIA. THE PRESENT STUDY TESTED THE HYPOTHESIS THAT PROMOTER METHYLATION/DEMETHYLATION IS A KEY MECHANISM IN EPIGENETIC REPROGRAMMING OF BKBETA1 EXPRESSION PATTERNS IN UTERINE ARTERIES. OVINE BKBETA1 PROMOTER OF 2315 BP SPANNING FROM -2211 TO +104 OF THE TRANSCRIPTION START SITE WAS CLONED, AND AN SP1-380 BINDING SITE THAT CONTAINS CPG DINUCLEOTIDE IN ITS CORE BINDING SEQUENCES WAS IDENTIFIED. SITE-DIRECTED DELETION OF THE SP1 SITE SIGNIFICANTLY DECREASED THE BKBETA1 PROMOTER ACTIVITY. ESTROGEN RECEPTOR-ALPHA BOUND TO THE SP1 SITE THROUGH TETHERING TO SP1 AND UPREGULATED THE EXPRESSION OF BKBETA1. THE SP1 BINDING SITE AT BKBETA1 PROMOTER WAS HIGHLY METHYLATED IN UTERINE ARTERIES OF NONPREGNANT SHEEP, AND METHYLATION INHIBITED TRANSCRIPTION FACTOR BINDING AND BKBETA1 PROMOTER ACTIVITY. PREGNANCY CAUSED A SIGNIFICANT DECREASE IN CPG METHYLATION AT THE SP1 BINDING SITE AND INCREASED SP1 BINDING TO THE BKBETA1 PROMOTER AND BKBETA1 MRNA ABUNDANCE. CHRONIC HYPOXIA DURING GESTATION ABROGATED THIS PREGNANCY-INDUCED DEMETHYLATION AND UPREGULATION OF BKBETA1 EXPRESSION. THE RESULTS PROVIDE EVIDENCE OF A NOVEL MECHANISM OF PROMOTER DEMETHYLATION IN PREGNANCY-INDUCED REPROGRAMMING OF LARGE-CONDUCTANCE CA(2+)-ACTIVATED POTASSIUM CHANNEL EXPRESSION AND FUNCTION IN UTERINE ARTERIES AND SUGGEST NEW INSIGHTS OF EPIGENETIC MECHANISMS LINKING GESTATIONAL HYPOXIA TO ABERRANT UTEROPLACENTAL CIRCULATION AND INCREASED RISK OF PREECLAMPSIA. 2014 2 919 70 CHRONIC HYPOXIA DURING GESTATION CAUSES EPIGENETIC REPRESSION OF THE ESTROGEN RECEPTOR-ALPHA GENE IN OVINE UTERINE ARTERIES VIA HEIGHTENED PROMOTER METHYLATION. ESTROGEN RECEPTOR-ALPHA (ERALPHA) PLAYS A KEY ROLE IN THE ADAPTATION OF INCREASED UTERINE BLOOD FLOW IN PREGNANCY. CHRONIC HYPOXIA IS A COMMON STRESS TO MATERNAL CARDIOVASCULAR HOMEOSTASIS AND CAUSES INCREASED RISK OF PREECLAMPSIA. STUDIES IN PREGNANT SHEEP DEMONSTRATED THAT HYPOXIA DURING GESTATION DOWNREGULATED ERALPHA GENE EXPRESSION IN UTERINE ARTERIES. THE PRESENT STUDY TESTED THE HYPOTHESIS THAT HYPOXIA CAUSES EPIGENETIC REPRESSION OF THE ERALPHA GENE IN UTERINE ARTERIES VIA HEIGHTENED PROMOTER METHYLATION. OVINE ERALPHA PROMOTER OF 2035 BP SPANNING FROM -2000 TO +35 OF THE TRANSCRIPTION START SITE WAS CLONED. NO ESTROGEN OR HYPOXIA-INDUCIBLE FACTOR RESPONSE ELEMENTS WERE FOUND AT THE PROMOTER. TWO TRANSCRIPTION FACTOR BINDING SITES, USF(-15) AND SP1(-520), CONTAINING CPG DINUCLEOTIDES WERE IDENTIFIED, WHICH HAD SIGNIFICANT EFFECTS ON THE PROMOTER ACTIVITY. THE USF ELEMENT BINDS TRANSCRIPTION FACTORS USF1 AND USF2, AND THE SP1 ELEMENT BINDS SP1, AS WELL AS ERALPHA THROUGH SP1. DELETION OF THE SP1 SITE ABROGATED 17BETA-ESTRADIOL-INDUCED INCREASE IN THE PROMOTER ACTIVITY. IN NORMOXIC CONTROL SHEEP, CPG METHYLATION AT THE SP1 BUT NOT THE USF SITE WAS SIGNIFICANTLY DECREASED IN UTERINE ARTERIES OF PREGNANT AS COMPARED WITH NONPREGNANT ANIMALS. IN PREGNANT SHEEP EXPOSED TO LONG-TERM HIGH-ALTITUDE HYPOXIA, CPG METHYLATION AT BOTH SP1 AND USF SITES IN UTERINE ARTERIES WAS SIGNIFICANTLY INCREASED. METHYLATION INHIBITED TRANSCRIPTION FACTOR BINDING AND THE PROMOTER ACTIVITY. THE RESULTS PROVIDE EVIDENCE OF HYPOXIA CAUSING HEIGHTENED PROMOTER METHYLATION AND RESULTANT ERALPHA GENE REPRESSION IN UTERINE ARTERIES AND SUGGEST NEW INSIGHTS OF MOLECULAR MECHANISMS LINKING GESTATIONAL HYPOXIA TO ABERRANT UTEROPLACENTAL CIRCULATION AND INCREASED RISK OF PREECLAMPSIA. 2012 3 840 26 CHEMOENZYMATIC LABELING OF DNA METHYLATION PATTERNS FOR SINGLE-MOLECULE EPIGENETIC MAPPING. DNA METHYLATION, SPECIFICALLY, METHYLATION OF CYTOSINE (C) NUCLEOTIDES AT THE 5-CARBON POSITION (5-MC), IS THE MOST STUDIED AND SIGNIFICANT EPIGENETIC MODIFICATION. HERE WE DEVELOPED A CHEMOENZYMATIC PROCEDURE TO FLUORESCENTLY LABEL NON-METHYLATED CYTOSINES IN CPG CONTEXT, ALLOWING EPIGENETIC PROFILING OF SINGLE DNA MOLECULES SPANNING HUNDREDS OF THOUSANDS OF BASE PAIRS. WE USED A CPG METHYLTRANSFERASE WITH A SYNTHETIC S-ADENOSYL-L-METHIONINE COFACTOR ANALOG TO TRANSFER AN AZIDE TO CYTOSINES INSTEAD OF THE NATURAL METHYL GROUP. A FLUOROPHORE WAS THEN CLICKED ONTO THE DNA, REPORTING ON THE AMOUNT AND POSITION OF NON-METHYLATED CPGS. WE FOUND THAT LABELING EFFICIENCY WAS INCREASED UP TO 2-FOLD BY THE ADDITION OF A NUCLEOSIDASE, PRESUMABLY BY DEGRADING THE INACTIVE BY-PRODUCT OF THE COFACTOR AFTER LABELING, PREVENTING ITS INHIBITORY EFFECT. WE USED THE METHOD TO DETERMINE THE DECLINE IN GLOBAL DNA METHYLATION IN A CHRONIC LYMPHOCYTIC LEUKEMIA PATIENT AND THEN PERFORMED WHOLE-GENOME METHYLATION MAPPING OF THE MODEL PLANT ARABIDOPSIS THALIANA. OUR GENOME MAPS SHOW HIGH CONCORDANCE WITH PUBLISHED BISULFITE SEQUENCING METHYLATION MAPS. ALTHOUGH MAPPING RESOLUTION IS LIMITED BY OPTICAL DETECTION TO 500-1000 BP, THE LABELED DNA MOLECULES PRODUCED BY THIS APPROACH ARE HUNDREDS OF THOUSANDS OF BASE PAIRS LONG, ALLOWING ACCESS TO LONG REPETITIVE AND STRUCTURALLY VARIABLE GENOMIC REGIONS. 2022 4 519 28 ASSOCIATIONS BETWEEN GENETIC AND EPIGENETIC VARIATIONS IN CYTOKINE GENES AND MILD PERSISTENT BREAST PAIN IN WOMEN FOLLOWING BREAST CANCER SURGERY. PERSISTENT PAIN FOLLOWING BREAST CANCER SURGERY IS A SIGNIFICANT PROBLEM. BOTH INHERITED AND ACQUIRED MECHANISMS OF INFLAMMATION APPEAR TO PLAY A ROLE IN THE DEVELOPMENT AND MAINTENANCE OF PERSISTENT PAIN. IN THIS LONGITUDINAL STUDY, GROWTH MIXTURE MODELING WAS USED TO IDENTIFY PERSISTENT BREAST PAIN PHENOTYPES BASED ON PAIN ASSESSMENTS OBTAINED PRIOR TO AND MONTHLY FOR 6MONTHS FOLLOWING BREAST CANCER SURGERY. ASSOCIATIONS BETWEEN THE "NO PAIN" AND "MILD PAIN" PHENOTYPES AND SINGLE NUCLEOTIDE POLYMORPHISMS (SNPS) SPANNING 15 CYTOKINE GENES WERE EVALUATED. THE METHYLATION STATUS OF THE CPG SITES FOUND IN THE PROMOTERS OF GENES ASSOCIATED WITH PAIN GROUP MEMBERSHIP WAS DETERMINED USING BISULFITE SEQUENCING. IN THE MULTIVARIATE ANALYSIS, THREE SNPS (I.E., INTERLEUKIN 6 (IL6) RS2069840, C-X-C MOTIF CHEMOKINE LIGAND 8 (CXCL8) RS4073, TUMOR NECROSIS FACTOR (TNF) RS1800610) AND TWO TNF CPG SITES (I.E., C.-350C, C.-344C) WERE ASSOCIATED WITH PAIN GROUP MEMBERSHIP. THESE FINDINGS SUGGEST THAT VARIATIONS IN IL6, CXCL8, AND TNF ARE ASSOCIATED WITH THE DEVELOPMENT AND MAINTENANCE OF MILD PERSISTENT BREAST PAIN. CPG METHYLATION WITHIN THE TNF PROMOTER MAY PROVIDE AN ADDITIONAL MECHANISM THROUGH WHICH TNF ALTERS THE RISK FOR MILD PERSISTENT BREAST PAIN AFTER BREAST CANCER SURGERY. THESE GENETIC AND EPIGENETIC VARIATIONS MAY HELP TO IDENTIFY INDIVIDUALS WHO ARE PREDISPOSED TO THE DEVELOPMENT OF MILD LEVELS OF PERSISTENT BREAST PAIN FOLLOWING BREAST CANCER SURGERY. 2017 5 2756 24 EXPRESSION OF DNA METHYLTRANSFERASES IN ADULT DORSAL ROOT GANGLIA IS CELL-TYPE SPECIFIC AND UP REGULATED IN A RODENT MODEL OF NEUROPATHIC PAIN. NEUROPATHIC PAIN IS ASSOCIATED WITH HYPEREXCITABILITY AND INTRINSIC FIRING OF DORSAL ROOT GANGLIA (DRG) NEURONS. THESE PHENOTYPICAL CHANGES CAN BE LONG LASTING, POTENTIALLY SPANNING THE ENTIRE LIFE OF ANIMAL MODELS, AND DEPEND ON ALTERED EXPRESSION OF NUMEROUS PROTEINS, INCLUDING MANY ION CHANNELS. YET, HOW DRGS MAINTAIN LONG-TERM CHANGES IN PROTEIN EXPRESSION IN NEUROPATHIC CONDITIONS REMAINS UNCLEAR. DNA METHYLATION IS A WELL-KNOWN MECHANISM OF EPIGENETIC CONTROL OF GENE EXPRESSION AND IS ACHIEVED BY THE ACTION OF THREE ENZYMES: DNA METHYLTRANSFERASE (DNMT) 1, 3A, AND 3B, WHICH HAVE BEEN STUDIED PRIMARILY DURING DEVELOPMENT. WE FIRST PERFORMED IMMUNOHISTOCHEMICAL ANALYSIS TO ASSESS WHETHER THESE ENZYMES ARE EXPRESSED IN ADULT RAT DRGS (L4-5) AND FOUND THAT DNMT1 IS EXPRESSED IN BOTH GLIA AND NEURONS, DNMT3A IS PREFERENTIALLY EXPRESSED IN GLIA AND DNMT3B IS PREFERENTIALLY EXPRESSED IN NEURONS. A RAT MODEL OF NEUROPATHIC PAIN WAS THEN USED TO DETERMINE WHETHER NERVE INJURY MAY INDUCE EPIGENETIC CHANGES IN DRGS AT MULTIPLE TIME POINTS AFTER PAIN ONSET. REAL-TIME RT PCR ANALYSIS REVEALED ROBUST AND TIME-DEPENDENT CHANGES IN DNMT TRANSCRIPT EXPRESSION IN IPSILATERAL DRGS FROM SPARED NERVE INJURY (SNI) BUT NOT SHAM RATS. INTERESTINGLY, DNMT3B TRANSCRIPT SHOWED A ROBUST UPREGULATION THAT APPEARED ALREADY 1 WEEK AFTER SURGERY AND PERSISTED AT 4 WEEKS (OUR ENDPOINT); IN CONTRAST, DNMT1 AND DNMT3A TRANSCRIPTS SHOWED ONLY MODERATE UPREGULATION THAT WAS TRANSIENT AND DID NOT APPEAR UNTIL THE SECOND WEEK. WE SUGGEST THAT DNMT REGULATION IN ADULT DRGS MAY BE A CONTRIBUTOR TO THE PAIN PHENOTYPE AND MERITS FURTHER STUDY. 2014 6 4408 31 MOLECULAR ANALYSIS OF THE FRAGILE HISTIDINE TRIAD (FHIT) TUMOR SUPPRESSOR GENE IN VESICAL TUMORS OF CATTLE WITH CHRONIC ENZOOTIC HEMATURIA (CEH). THE FHIT (FRAGILE HISTIDINE TRIAD) GENE IS A TUMOR SUPPRESSOR GENE KNOWN TO BE INACTIVATED IN MANY TUMORS INCLUDING BLADDER TUMORS AND IS SPANNING FRA3B, A VERY ACTIVE COMMON FRAGILE SITE IN THE HUMAN GENOME. WE HAVE RECENTLY ISOLATED THE BOVINE GENE, AND THE AIM OF THIS STUDY WAS TO TEST WHETHER FHIT PRESENTS ALTERED EXPRESSION PATTERNS IN VESICAL TUMORS OF CATTLE WITH CEH (CHRONIC ENZOOTIC HEMATURIA). CEH IS A COMMON SYNDROME AFFECTING MEDITERRANEAN CATTLE: CLASTOGENIC, MUTAGENIC AND CANCEROGENIC SUBSTANCES RELEASED BY THE BRACKEN FERN (PTERIDIUM SPP) GRAZED BY ANIMALS INDUCE THE FORMATION OF NEOPLASTIC LESIONS, AMONG WHICH BLADDER TUMORS HAVE A HIGH INCIDENCE. WE ANALYSED FHIT IN 23 BLADDER TUMORS OF CEH CATTLE LOOKING AT: 1) THE METHYLATION STATUS OF THE CPG ISLAND COMPRISING THE PROMOTER AND PART OF EXON 1; 2) THE PRESENCE OF ALTERED FHIT TRANSCRIPTS; 3) THE MRNA EXPRESSION LEVELS MEASURED WITH A QUANTITATIVE REAL TIME PCR (QRT-PCR) APPROACH. OUR RESULTS SUGGEST THAT UNLIKE IN HUMAN TUMORS, FHIT IN VESICAL TUMORS OF CEH CATTLE IS LARGELY UNMETHYLATED. FURTHERMORE, THE SAME MRNA ISOFORMS OF FHIT WERE DETECTED IN TUMORS AND IN HEALTHY TISSUES, INCLUDING A NOVEL ISOFORM THAT WAS FOUND IN THIS STUDY. FINALLY, QRT-PCR DATA DID NOT REVEAL SIGNIFICANTLY ALTERED EXPRESSION PROFILES OF FHIT TRANSCRIPTS. FURTHER STUDIES AND LARGER SETS OF CASES WILL BE USEFUL TO CONFIRM THIS FINDING, BUT THE DATA SEEM TO SUGGEST THAT EPIGENETIC MODIFICATIONS OF FHIT AND ALTERED EXPRESSION PROFILES ARE NOT A HALLMARK OF BOVINE VESICAL TUMORS LIKE THEY ARE IN HUMAN TUMORS. 2008 7 3051 22 GENOME-WIDE ASSOCIATION ANALYSIS OF EOSINOPHILIC ESOPHAGITIS PROVIDES INSIGHT INTO THE TISSUE SPECIFICITY OF THIS ALLERGIC DISEASE. EOSINOPHILIC ESOPHAGITIS (EOE) IS A CHRONIC INFLAMMATORY DISORDER ASSOCIATED WITH ALLERGIC HYPERSENSITIVITY TO FOOD. WE INTERROGATED >1.5 MILLION GENETIC VARIANTS IN EOE CASES OF EUROPEAN ANCESTRY AND SUBSEQUENTLY IN A MULTI-SITE COHORT WITH LOCAL AND OUT-OF-STUDY CONTROL SUBJECTS. IN ADDITION TO REPLICATING ASSOCIATION OF THE 5Q22 LOCUS (META-ANALYSIS P=1.9X10(-16)), WE IDENTIFIED AN ASSOCIATION AT 2P23 SPANNING CAPN14 (P=2.5X10(-10)). CAPN14 WAS SPECIFICALLY EXPRESSED IN THE ESOPHAGUS, WAS DYNAMICALLY UPREGULATED AS A FUNCTION OF DISEASE ACTIVITY AND GENETIC HAPLOTYPE AND AFTER EXPOSURE OF EPITHELIAL CELLS TO INTERLEUKIN (IL)-13, AND WAS LOCATED IN AN EPIGENETIC HOTSPOT MODIFIED BY IL-13. GENES NEIGHBORING THE TOP 208 EOE-ASSOCIATED SEQUENCE VARIANTS WERE ENRICHED FOR ESOPHAGEAL EXPRESSION, AND MULTIPLE LOCI FOR ALLERGIC SENSITIZATION WERE ASSOCIATED WITH EOE SUSCEPTIBILITY (4.8X10(-2)